FDA Application
-
NDC Search Results on Active Ingredient: methotrexate
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
METHOTREXATE | 54436-017-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-020-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-020-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-020-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-020-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-022-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-022-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-022-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-022-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-025-01 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-025-02 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-025-03 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE | 54436-025-04 | Antares Pharma, Inc. | NDA204824 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 59137-505-00 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 59137-505-01 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 59137-505-04 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 59137-510-00 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 59137-510-01 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 59137-510-04 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 59137-515-00 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 59137-515-01 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 59137-515-04 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 59137-520-00 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 59137-520-01 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 59137-520-04 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 59137-525-00 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 59137-525-01 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 59137-525-04 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 59137-530-00 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
METHOTREXATE SODIUM | 59137-530-01 | Medexus Pharma Inc. | NDA205776 | HUMAN PRESCRIPTION DRUG | NDA |
1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-170 |
-